Rothschild Investment LLC’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39K | Hold |
100
| – | – | ﹤0.01% | 1946 |
|
|
2025
Q1 | $2.49K | Buy |
100
+10
| +11% | +$249 | ﹤0.01% | 1761 |
|
|
2024
Q4 | $1.7K | Buy |
90
+70
| +350% | +$1.32K | ﹤0.01% | 1906 |
|
|
2024
Q3 | $301 | Sell |
20
-72,972
| -100% | -$1.1M | ﹤0.01% | 2609 |
|
|
2024
Q2 | $2.09M | Buy |
72,992
+33,098
| +83% | +$947K | 0.15% | 132 |
|
|
2024
Q1 | $1.17M | Buy |
39,894
+39,273
| +6,324% | +$1.15M | 0.08% | 210 |
|
|
2023
Q4 | $21K | Sell |
621
-39,463
| -98% | -$1.33M | ﹤0.01% | 851 |
|
|
2023
Q3 | $1.23M | Sell |
40,084
-243
| -0.6% | -$7.46K | 0.1% | 181 |
|
|
2023
Q2 | $1.62M | Buy |
40,327
+31,033
| +334% | +$1.24M | 0.13% | 145 |
|
|
2023
Q1 | $379K | Hold |
9,294
| – | – | 0.03% | 335 |
|
|
2022
Q4 | $359K | Buy |
9,294
+63
| +0.7% | +$2.43K | 0.03% | 338 |
|
|
2022
Q3 | $491K | Hold |
9,231
| – | – | 0.05% | 281 |
|
|
2022
Q2 | $539K | Buy |
9,231
+174
| +2% | +$10.2K | 0.05% | 279 |
|
|
2022
Q1 | $692K | Buy |
9,057
+134
| +2% | +$10.2K | 0.05% | 269 |
|
|
2021
Q4 | $537K | Hold |
8,923
| – | – | 0.04% | 316 |
|
|
2021
Q3 | $500K | Sell |
8,923
-10
| -0.1% | -$560 | 0.04% | 311 |
|
|
2021
Q2 | $542K | Sell |
8,933
-248
| -3% | -$15K | 0.04% | 312 |
|
|
2021
Q1 | $643K | Buy |
9,181
+991
| +12% | +$69.4K | 0.06% | 273 |
|
|
2020
Q4 | $490K | Sell |
8,190
-808
| -9% | -$48.3K | 0.05% | 289 |
|
|
2020
Q3 | $541K | Buy |
8,998
+939
| +12% | +$56.5K | 0.06% | 253 |
|
|
2020
Q2 | $423K | Sell |
8,059
-17,754
| -69% | -$932K | 0.05% | 270 |
|
|
2020
Q1 | $866K | Buy |
25,813
+19,204
| +291% | +$644K | 0.11% | 178 |
|
|
2019
Q4 | $299K | Buy |
+6,609
| New | +$299K | 0.03% | 360 |
|